To amend the Controlled Substances Act to require certain training as a condition of registration to prescribe or dispense opioids for the treatment of pain or pain management, and for other purposes.
USA115th CongressHR-2063| House
| Updated: 5/1/2017
Bradley Scott Schneider
Democratic Representative
Illinois
Cosponsors (13)
Ruben Gallego (Democratic)David N. Cicilline (Democratic)Derek Kilmer (Democratic)Ted Lieu (Democratic)Ro Khanna (Democratic)Sean Patrick Maloney (Democratic)Jerrold Nadler (Democratic)Theodore E. Deutch (Democratic)Mike Quigley (Democratic)Janice D. Schakowsky (Democratic)Adam Smith (Democratic)Nydia M. Velázquez (Democratic)Earl Blumenauer (Democratic)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Opioid Preventing Abuse through Continuing Education Act of 2017 or the Opioid PACE Act of 2017 This bill amends the Controlled Substances Act to require a practitioner (other than a hospital, pharmacy, pharmacist, or veterinarian) to comply with a training requirement, as a condition of obtaining or renewing a registration to prescribe or dispense opioids for the treatment of pain or pain management.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Health
Drug, alcohol, tobacco useDrug trafficking and controlled substancesHealth personnelLaw enforcement administration and fundingLicensing and registrationsMedical educationPrescription drugs
To amend the Controlled Substances Act to require certain training as a condition of registration to prescribe or dispense opioids for the treatment of pain or pain management, and for other purposes.
USA115th CongressHR-2063| House
| Updated: 5/1/2017
Opioid Preventing Abuse through Continuing Education Act of 2017 or the Opioid PACE Act of 2017 This bill amends the Controlled Substances Act to require a practitioner (other than a hospital, pharmacy, pharmacist, or veterinarian) to comply with a training requirement, as a condition of obtaining or renewing a registration to prescribe or dispense opioids for the treatment of pain or pain management.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Bradley Scott Schneider
Democratic Representative
Illinois
Cosponsors (13)
Ruben Gallego (Democratic)David N. Cicilline (Democratic)Derek Kilmer (Democratic)Ted Lieu (Democratic)Ro Khanna (Democratic)Sean Patrick Maloney (Democratic)Jerrold Nadler (Democratic)Theodore E. Deutch (Democratic)Mike Quigley (Democratic)Janice D. Schakowsky (Democratic)Adam Smith (Democratic)Nydia M. Velázquez (Democratic)Earl Blumenauer (Democratic)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Drug, alcohol, tobacco useDrug trafficking and controlled substancesHealth personnelLaw enforcement administration and fundingLicensing and registrationsMedical educationPrescription drugs